article thumbnail

The Pharmaceutical Industry’s Relationship With Cannabis

Kind Meds (Cannabis Education Blog)

Over the years, it has gone from being commonly used to a controversial topic. At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country. Cannabis has had a long, changing history in the United States. Its current value sits at over one trillion dollars.

article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

Pharmaceutical grade cannabis is relatively new in parts of the world. Legal access does not necessarily equate to financial access. Although there is growing access to cannabis medicines, there is an increasing need for credible research and educational platforms.

Access 89
article thumbnail

Hemp-derived CBD Vs Cannabis-derived CBD in topicals

Marijuanally

CBD is a hot topic these days. The FDA recently approved a CBD-based drug to help treat childhood epilepsy such as Dravet’s Syndrome which is difficult to treat with conventional pharmaceuticals. Accessibility is higher with Hemp derived CBD products. Which one is better? Products containing less than.3% Meaning that.

Topical 73
article thumbnail

Virginia: New Medical Cannabis Laws Take Effect July 1

NORML

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. Now, patients can expect to see products typical of compounding pharmacies, like capsules, topicals, lozenges, lollipops, and suppositories, with an allowance of up to 10 milligrams of THC each.

Law 258
article thumbnail

Hemp-derived CBD Vs Cannabis-derived CBD in topicals

Marijuanally

CBD is a hot topic these days. The FDA recently approved a CBD-based drug to help treat childhood epilepsy such as Dravet’s Syndrome which is difficult to treat with conventional pharmaceuticals. Accessibility is higher with Hemp derived CBD products. Which one is better? Products containing less than.3% Meaning that.

Topical 40
article thumbnail

Clever Leaves Jumps Into Mexico’s CBD Market

Cannabis Law Report

NASDAQ: CLVR) said it has entered into an active pharmaceutical ingredient supply agreement with CBD Life Holding SAPI de CV, an emerging leader in the Mexican cannabis industry which offers a line of CBD Wellness and consumer products and medical cannabis products which are under development. Clever Leaves Holdings Inc.

CBD 111